COMMUNIQUÉS West-GlobeNewswire

Hypersanté Hosts First Francophone Summit on Longevity and Biohacking in Paris
03/03/2026
A $30 Billion Industry Redefining Preventive Medicine Paris, ÎLE-DE-FRANCE, March 03, 2026 (GLOBE NEWSWIRE) -- For decades, longevity sat at two opposite ends of the spectrum: cutting-edge medicine for the ultra-wealthy [...]
Testosterone Booster Supplement for Men Over 50 — TestoPrime Medically Accredited by Clinicians' Choice in 2026
03/03/2026
As of March 2026, TestoPrime is available in over 130 countries and holds the Clinicians' Choice medical accreditation as natural testosterone supplement for men. New York City, NY, March 03, 2026 (GLOBE NEWSWIRE) -- [...]
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026
03/03/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature handheld robotics and digital solutions for hip, knee and shoulder in addition to innovative trauma and extremities [...]
Résultats 2025 : amélioration de la marge de Core EBITDA en dépit de vents contraires sur l’activité, grâce à une stricte discipline financière
03/03/2026
Communiqué de presse Paris, le 3 mars 2026 Avancée de FOCUS-27 dans un environnement plus difficile Accélération de la transformation pour renforcer le modèle opérationnel Résultats 2025 Chiffre d’affaires de 848,2 [...]
2025 results: Core EBITDA margin improved despite sales headwinds, driven by strong cost discipline
03/03/2026
Press Release Paris, 3 rd March, 2026 Progress against FOCUS-27 in a deteriorating environment Accelerated transformation to strengthen the operating model Full-year 2025 results €848.2 million net sales (7.0) % decline [...]
Sympathiq Launches Well-Being Marketplace Connecting UK Residents with Certified Mental Health Specialists
03/03/2026
London, UK, March 03, 2026 (GLOBE NEWSWIRE) -- Sympathiq Ltd , a digital health technology company, announced today the launch of its online well-being marketplace, designed to connect residents across the United [...]
Suzanne Nora Johnson Joins Wellcome Leap Board of Directors
03/03/2026
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Wellcome Leap (Leap), a U.S. nonprofit founded by the Wellcome Trust to accelerate breakthroughs in human health, today announced that Suzanne Nora Johnson has joined its [...]
TimelyCare Honored as Virtual Student Health and Wellness Services Company of the Year 2026 by Education Insider
03/03/2026
Recognition Highlights Transformative Mental Health Outcomes and Student Retention Fort Worth, TX, March 03, 2026 (GLOBE NEWSWIRE) -- TimelyCare , education’s most trusted virtual health and well-being provider, has [...]
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference
03/03/2026
SOUTH SAN FRANCISCO, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its [...]
PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm, an AI-Powered Pathology Solution to Transform Dermatopathology Workflow
03/03/2026
BOSTON, March 03, 2026 (GLOBE NEWSWIRE) -- PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted [...]
Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing
03/03/2026
Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”), a Delaware-incorporated, clinical-stage oncology biotechnology company, today announced its official launch following a [...]
Spryte Medical Announces First Participants Enrolled in the INSYTE Trial at Baptist Health Jacksonville
03/03/2026
FDA-approved IDE trial to evaluate the safety and effectiveness of the nOCT™ Imaging System to provide quality images for diagnostic assessment during endovascular intracranial aneurysm treatment and follow-up BEDFORD, [...]
Tekton Research Appoints Dr. Jara McDonald as Executive Medical Director to Support Continued Growth in Cardiometabolic Research
03/03/2026
Double Board-Certified Obesity, Diabetes & Integrative Medicine Specialist to Lead Medical Strategy, Sponsor Engagement, and Industry Collaboration AUSTIN, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Tekton Research, [...]
LiveWorld Launches Integrated GEO, AIO and SEO Search Optimization for Healthcare and Pharma Brands
03/03/2026
A unified solution combining AI and SEO audits, prompt and keyword intelligence, and AI-optimized content creation to ensure brands lead in both organic search and AI-generated answers CAMPBELL, Calif. and NEW YORK, [...]
Hot Springs Arkansas Neurologist Kara Way Opens New Way Neurology
03/03/2026
HOT SPRINGS, Ark., March 03, 2026 (GLOBE NEWSWIRE) -- New Way Neurology is now open and serving patients at 100 Ridgeway St., Suite 2, in Hot Springs. The new practice is led by Board-certified neurologist Kara Way, MD [...]
Human Appeal hosts global Grand Iftars, providing over 250,000 meals for vulnerable people this Ramadan
03/03/2026
Humanitarian charity running large scale Iftars for displaced peoples across Palestine, Iraq, Pakistan, Somalia, Sudan, Syria and Yemen MANCHESTER, United Kingdom, March 03, 2026 (GLOBE NEWSWIRE) -- Leading global [...]
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
03/03/2026
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care [...]
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
03/03/2026
HINGHAM, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced today that the Company, both in the [...]
PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders
03/03/2026
TORONTO, March 03, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) , a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives [...]

Pages